Working… Menu

Investigating the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus (EU-TREAT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02662114
Recruitment Status : Completed
First Posted : January 25, 2016
Last Update Posted : May 2, 2019
Information provided by (Responsible Party):
Novo Nordisk A/S